First Affiliated Hospital Of Zhejiang University
Clinical trials sponsored by First Affiliated Hospital Of Zhejiang University, explained in plain language.
-
New drug combo shows promise against tough bile duct cancer
Disease control OngoingThis study tests whether giving a mix of immunotherapy (camrelizumab), a targeted drug (apatinib), and chemotherapy (GEMOX) before and after surgery can help people with advanced bile duct cancer. The goal is to shrink tumors enough for successful removal and to prevent the cance…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
Younger relatives may be better stem cell donors for blood cancer patients
Disease control OngoingThis study looks at whether using stem cells from a younger, more distant relative leads to better survival than using cells from an older immediate family member for people with leukemia or MDS. About 232 participants will be randomly assigned to receive a transplant from either…
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 15, 2026 11:52 UTC
-
AI reads 2 million CT scans to spot hidden diseases
Diagnosis OngoingThis study aims to create an AI system that helps doctors interpret abdominal CT scans more accurately. Researchers will use data from 2 million patients to train the AI to detect and describe lesions. The goal is to reduce errors and speed up diagnosis for abdominal diseases.
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated May 13, 2026 16:00 UTC
-
Brain wave clues could spot delirium risk in seniors after surgery
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at brain wave (EEG) patterns in older adults during and after surgery to see if they can predict postoperative delirium—a state of confusion that can occur after anesthesia. Researchers will monitor 375 patients aged 60 and older undergoing joint replacement or s…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 16, 2026 23:50 UTC
-
Researchers track gene changes in myelofibrosis patients on gecacitinib
Knowledge-focused OngoingThis study follows about 40 people with intermediate- or high-risk myelofibrosis who have already been taking gecacitinib in earlier studies. Researchers will collect bone marrow and blood samples once a year to see if the disease grade or certain gene mutations change over time.…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC